These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
838 related articles for article (PubMed ID: 28417924)
1. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
2. Folate-receptor-targeted laser-activable poly(lactide- Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting of paclitaxel-loaded poly(lactic- Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603 [TBL] [Abstract][Full Text] [Related]
6. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer. Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051 [TBL] [Abstract][Full Text] [Related]
7. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles. Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309 [TBL] [Abstract][Full Text] [Related]
8. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
10. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
11. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells loaded with paclitaxel-poly(lactic- Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710 [TBL] [Abstract][Full Text] [Related]
13. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma. Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806 [TBL] [Abstract][Full Text] [Related]
14. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations. Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936 [TBL] [Abstract][Full Text] [Related]
15. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles. Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749 [TBL] [Abstract][Full Text] [Related]
16. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer. Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy. Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837 [TBL] [Abstract][Full Text] [Related]
18. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma. Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913 [TBL] [Abstract][Full Text] [Related]
20. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]